Soleno Therapeutics Inc. (SLNO)
45.89
3.35 (7.87%)
At close: Jan 15, 2025, 12:04 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -38.99M | -24.07M | -30.91M | -24.64M | -30.77M | -11.84M | -12.07M | -12.07M | -15.91M | -13.87M | -3.71M | -6.48M |
| Depreciation & Amortization | 1.96M | 1.96M | 1.96M | 1.95M | 1.96M | 1.96M | 1.61M | 131.64K | 108.23K | 28.52K | 42.11K | 43.79K |
| Stock-Based Compensation | 5.95M | 2.53M | 3.28M | 1.50M | 825.00K | 988.00K | 880.03K | 871.27K | 942.37K | 345.44K | 38.42K | 24.41K |
| Other Working Capital | 1.56M | 721.00K | -913.00K | 1.48M | 1.44M | -167.00K | -214.70K | -579.67K | 1.20M | -94.32K | -12.65M | -16.59K |
| Other Non-Cash Items | 3.22M | -452.00K | -443.00K | 4.62M | 1.15M | 1.00M | 1.31M | -1.64M | 183.32K | 4.13M | 2.86M | 2.87M |
| Deferred Income Tax | n/a | n/a | -508.00K | -11.64M | 6.96M | -3.88M | -1.65M | 21.70K | 3.57M | 4.59M | 106.77K | 22.41K |
| Change in Working Capital | 2.93M | -756.00K | -1.15M | 2.98M | 2.50M | 82.00K | -24.07K | -815.43K | 810.06K | 299.85K | -225.54K | 28.88K |
| Operating Cash Flow | -24.94M | -20.78M | -27.77M | -25.22M | -17.38M | -11.68M | -9.95M | -13.50M | -10.30M | -4.48M | -885.22K | -3.50M |
| Capital Expenditures | n/a | -13.00K | -22.00K | -7.00K | -21.00K | -8.00K | -2.57K | -38.68K | -305.78K | -30.68K | -1.27K | -2.49K |
| Acquisitions | n/a | n/a | n/a | n/a | 500.00K | n/a | -572.59K | n/a | -1.00M | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -500.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 500.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | 49.00K | -172.00K | 953.94K | -23.89K | -15.00K | n/a | n/a | n/a |
| Investing Cash Flow | n/a | -13.00K | -22.00K | -7.00K | 528.00K | -180.00K | 378.78K | -38.68K | -1.32M | -30.68K | -1.27K | -2.49K |
| Debt Repayment | n/a | n/a | -8.00K | -17.00K | -2.00K | n/a | n/a | n/a | n/a | 2.59M | n/a | 5.00M |
| Common Stock Repurchased | n/a | n/a | -120 | n/a | n/a | n/a | n/a | -7.78M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 42.16M | -16.00K | -120.00K | 17.00K | n/a | 1.52M | -838.00K | 10.77M | 13.39M | -2.12M | n/a | 27.66K |
| Financial Cash Flow | 180.02M | 14.09M | -128.00K | 53.72M | 14.48M | 17.83M | 23.94M | 10.77M | 9.16M | 11.20M | n/a | 5.03M |
| Net Cash Flow | 155.08M | -6.70M | -27.92M | 28.49M | -2.37M | 5.96M | 14.37M | -2.77M | -2.46M | 6.69M | -886.49K | 1.53M |
| Free Cash Flow | -24.94M | -20.79M | -27.79M | -25.23M | -17.40M | -11.69M | -9.95M | -13.54M | -10.61M | -4.52M | -886.49K | -3.50M |